Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.

about

Plasma Homoarginine Concentrations According to Use of Hormonal Contraception

P2860

Q58778478-9B6F63F9-9567-47A0-AAE6-B50E05FE9031

P2860

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.

Item

http://www.wikidata.org/entity/Q47115685

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Asymmetric dimethylarginine (A ...... ADMA, SDMA and hArg paradoxes.

@en

Asymmetric dimethylarginine (A ...... ADMA, SDMA and hArg paradoxes.

@nl

type

Item

label

Asymmetric dimethylarginine (A ...... ADMA, SDMA and hArg paradoxes.

@en

Asymmetric dimethylarginine (A ...... ADMA, SDMA and hArg paradoxes.

@nl

prefLabel

Asymmetric dimethylarginine (A ...... ADMA, SDMA and hArg paradoxes.

@en

Asymmetric dimethylarginine (A ...... ADMA, SDMA and hArg paradoxes.

@nl

P1476

Asymmetric dimethylarginine (A ...... ADMA, SDMA and hArg paradoxes.

@en

P2093

Alexander Bollenbach

http://www.w3.org/2001/XMLSchema#string

Arslan Arinc Kayacelebi

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tsikas

http://www.w3.org/2001/XMLSchema#string

Erik Hanff

http://www.w3.org/2001/XMLSchema#string

P2860

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies

Protein arginine methylation regulates insulin signaling in L6 skeletal muscle cells.

Potent, long-acting luteinizing hormone-releasing hormone antagonists containing new synthetic amino acids: N,N'-dialkyl-D-homoarginines.

Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.

Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes.

Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report.

Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes.

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

P2888

s12933-017-0656-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1186/S12933-017-0656-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100190334

http://www.w3.org/2001/XMLSchema#string

P698

29301528

http://www.w3.org/2001/XMLSchema#string

P932

5753492

http://www.w3.org/2001/XMLSchema#string

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.

about

P2860

P2860

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932